Ennakl Automobiles S.A. (CBSE:NKL)
34.50
-0.42 (-1.20%)
At close: Aug 1, 2025
Intra-Cellular Therapies Balance Sheet
Financials in millions TND. Fiscal year is January - December.
Millions TND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Cash & Equivalents | 18.15 | 17.5 | 19.96 | 36.65 | 13.02 | Upgrade |
Cash & Short-Term Investments | 18.15 | 17.5 | 19.96 | 36.65 | 13.02 | Upgrade |
Cash Growth | 3.72% | -12.30% | -45.55% | 181.50% | -30.43% | Upgrade |
Accounts Receivable | 140.37 | 137.71 | 78.98 | 95.71 | 100.11 | Upgrade |
Other Receivables | 3.22 | 1.92 | 2.11 | 3.38 | 4.7 | Upgrade |
Receivables | 144.11 | 139.89 | 81.62 | 99.64 | 105.8 | Upgrade |
Inventory | 166.77 | 177.51 | 94.69 | 83.38 | 80.43 | Upgrade |
Prepaid Expenses | 3.19 | 2.15 | 0.74 | 1.1 | 0.56 | Upgrade |
Other Current Assets | 4.32 | 6 | 2.43 | 1.37 | 0.68 | Upgrade |
Total Current Assets | 338.16 | 351.48 | 202.46 | 222.81 | 200.82 | Upgrade |
Property, Plant & Equipment | 70.97 | 67.31 | 66.5 | 66.3 | 68.71 | Upgrade |
Long-Term Investments | 90.04 | 63.05 | 63.1 | 61.99 | 82.74 | Upgrade |
Other Intangible Assets | 1.36 | 1.72 | 1.47 | 0.84 | 0.24 | Upgrade |
Long-Term Deferred Tax Assets | 1.97 | 2.64 | 2.31 | 4.36 | 0.81 | Upgrade |
Other Long-Term Assets | 7.08 | 7.55 | 7.53 | 7.78 | 8 | Upgrade |
Total Assets | 510.95 | 495.31 | 345.36 | 366.2 | 363.58 | Upgrade |
Accounts Payable | 152.63 | 191.56 | 111.25 | 148 | 125.86 | Upgrade |
Accrued Expenses | 12.32 | 9.94 | 7.33 | 6.8 | 7.62 | Upgrade |
Short-Term Debt | 74.29 | 57.37 | 24.59 | 10.37 | 30.85 | Upgrade |
Current Portion of Long-Term Debt | 1.28 | 6.84 | 6.34 | 5.89 | 4.77 | Upgrade |
Current Portion of Leases | - | - | 0.12 | 0.56 | 0.69 | Upgrade |
Current Income Taxes Payable | 3.92 | 9.45 | 0.33 | 3.96 | 4.31 | Upgrade |
Current Unearned Revenue | 0.08 | 0.1 | 0.11 | 0.09 | 0.04 | Upgrade |
Other Current Liabilities | 1 | 3.52 | 1.98 | 1.79 | 2.74 | Upgrade |
Total Current Liabilities | 245.51 | 278.78 | 152.06 | 177.47 | 176.89 | Upgrade |
Long-Term Debt | 3.05 | 3.41 | 4.25 | 10.59 | 10.64 | Upgrade |
Long-Term Leases | 2.39 | 1.05 | 0.95 | 1.25 | 0.69 | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.03 | Upgrade |
Other Long-Term Liabilities | 7.05 | 8.35 | 8.05 | 12.94 | 9.41 | Upgrade |
Total Liabilities | 258.38 | 291.92 | 165.67 | 202.96 | 198.23 | Upgrade |
Common Stock | 30 | 30 | 30 | 30 | 30 | Upgrade |
Retained Earnings | 41.69 | 37.37 | 31.83 | 14.08 | 22.39 | Upgrade |
Comprehensive Income & Other | 180.86 | 136.01 | 117.85 | 119.16 | 112.96 | Upgrade |
Total Common Equity | 252.56 | 203.38 | 179.69 | 163.24 | 165.35 | Upgrade |
Minority Interest | 0 | 0 | 0 | 0 | 0 | Upgrade |
Shareholders' Equity | 252.56 | 203.39 | 179.69 | 163.24 | 165.35 | Upgrade |
Total Liabilities & Equity | 510.95 | 495.31 | 345.36 | 366.2 | 363.58 | Upgrade |
Total Debt | 81.01 | 68.67 | 36.26 | 28.66 | 47.63 | Upgrade |
Net Cash (Debt) | -62.85 | -51.16 | -16.3 | 7.99 | -34.61 | Upgrade |
Net Cash Per Share | -2.10 | -1.71 | -0.54 | 0.27 | -1.15 | Upgrade |
Filing Date Shares Outstanding | 30 | 30 | 30 | 30 | 30 | Upgrade |
Total Common Shares Outstanding | 30 | 30 | 30 | 30 | 30 | Upgrade |
Working Capital | 92.65 | 72.7 | 50.4 | 45.33 | 23.93 | Upgrade |
Book Value Per Share | 8.42 | 6.78 | 5.99 | 5.44 | 5.51 | Upgrade |
Tangible Book Value | 251.2 | 201.66 | 178.22 | 162.41 | 165.1 | Upgrade |
Tangible Book Value Per Share | 8.37 | 6.72 | 5.94 | 5.41 | 5.50 | Upgrade |
Land | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | Upgrade |
Buildings | 45.8 | 45.8 | 45.8 | 45.03 | 33.65 | Upgrade |
Machinery | 56.1 | 49.19 | 42.76 | 37.76 | 37.09 | Upgrade |
Construction In Progress | 1.57 | 0.97 | 0.61 | 0.83 | 13.13 | Upgrade |
Updated Apr 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.